{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:36:07Z","timestamp":1791354967925,"version":"4.3.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Angioimmunoblastic T-cell lymphoma (AITL) is the second most common peripheral T-cell lymphoma with unusual clinical and pathologic features and a poor prognosis despite intensive chemotherapy. Recent studies have suggested AITL derives from follicular helper T (TFH) cells, but the causative molecular pathways remain largely unknown. Here we show that approximately 50% of mice heterozygous for the \u201csan\u201d allele of Roquin develop tumors accompanied by hypergammaglobulinemia by 6 months of age. Affected lymph nodes displayed the histologic features diagnostic of AITL, except for the presence of expanded FDC networks. Accumulation of TFH cells preceded tumor development, and clonal rearrangements in the TCR-\u03b2 genes were present in most tumors. Furthermore, TFH cells exhibited increased clonality compared with non-TFH cells from the same lymph nodes, even in the absence of tumors. Genetic manipulations that prevent TFH development, such as deletion of ICOS, CD28, and SAP, partially or completely abrogated tumor development, confirming a TFH-derived origin. Roquinsan\/+ mice emerge as a useful model to investigate the molecular pathogenesis of AITL and for preclinical testing of therapies aimed at targeting dysregulated TFH cells or their consequences.<\/jats:p>","DOI":"10.1182\/blood-2011-07-365130","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T00:20:06Z","timestamp":1339719606000},"page":"812-821","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":47,"title":["Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice"],"prefix":"10.1182","volume":"120","author":[{"given":"Julia I.","family":"Ellyard","sequence":"first","affiliation":[{"name":"Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiongsun","family":"Chia","sequence":"additional","affiliation":[{"name":"Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro-Maria","family":"Rodriguez-Pinilla","sequence":"additional","affiliation":[{"name":"Pathology Department, Fundacion Jimenez Diaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Navarro-Gonzalez","sequence":"additional","affiliation":[{"name":"Renal Department, Canberra Hospital, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Pathology Department, MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Delfau-Larue","sequence":"additional","affiliation":[{"name":"Inserm U955, Universit\u00e9 Paris Est, Cr\u00e9teil, France; Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP); Immunologie Biologique, H\u00f4pital Henri Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Research Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Inserm U955, Universit\u00e9 Paris Est, AP-HP, and D\u00e9partement de Pathologie, H\u00f4pital Henri Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Cook","sequence":"additional","affiliation":[{"name":"Immunology Department, Canberra Hospital, Canberra, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Walters","sequence":"additional","affiliation":[{"name":"Renal Department, Canberra Hospital, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Jefe de Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola G.","family":"Vinuesa","sequence":"additional","affiliation":[{"name":"Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111821515466400_B1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project.","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"2","key":"2019111821515466400_B2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1985.tb02819.x","article-title":"Bone marrow biopsy findings in angioimmunoblastic lymphadenopathy.","volume":"61","author":"Ghani","year":"1985","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111821515466400_B3","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111821515466400_B4","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/1097-0142(19920515)69:10<2567::AID-CNCR2820691029>3.0.CO;2-M","article-title":"Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A.","volume":"69","author":"Murayama","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"2019111821515466400_B5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/10428199909145744","article-title":"Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A.","volume":"35","author":"Takemori","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2019111821515466400_B6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients.","volume":"86","author":"Lachenal","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2019111821515466400_B7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/1097-0142(19870115)59:2<208::AID-CNCR2820590205>3.0.CO;2-7","article-title":"Prognostic factors in angioimmunoblastic lymphadenopathy.","volume":"59","author":"Archimbaud","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"2019111821515466400_B8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000227687","article-title":"Angioimmunoblastic lymphadenopathy with dysproteinemia: lack of a prognostic value of clear cell morphology.","volume":"54","author":"Ch'ang","year":"1997","journal-title":"Oncology"},{"issue":"11","key":"2019111821515466400_B9","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"22","key":"2019111821515466400_B10","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"2019111821515466400_B11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2019111821515466400_B12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2019111821515466400_B13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2019111821515466400_B14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3324\/haematol.2009.010991","article-title":"The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"issue":"7041","key":"2019111821515466400_B15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature03555","article-title":"A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.","volume":"435","author":"Vinuesa","year":"2005","journal-title":"Nature"},{"issue":"8","key":"2019111821515466400_B16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ni.1902","article-title":"Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression.","volume":"11","author":"Glasmacher","year":"2010","journal-title":"Nat Immunol"},{"issue":"7167","key":"2019111821515466400_B17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature06253","article-title":"Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA.","volume":"450","author":"Yu","year":"2007","journal-title":"Nature"},{"issue":"9","key":"2019111821515466400_B18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1742-4658.2010.07628.x","article-title":"The ROQUIN family of proteins localizes to stress granules via the ROQ domain and binds target mRNAs.","volume":"277","author":"Athanasopoulos","year":"2010","journal-title":"FEBS J"},{"issue":"2","key":"2019111821515466400_B19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.immuni.2008.12.015","article-title":"Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS.","volume":"30","author":"Linterman","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"2019111821515466400_B20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.20081886","article-title":"Follicular helper T cells are required for systemic autoimmunity.","volume":"206","author":"Linterman","year":"2009","journal-title":"J Exp Med"},{"issue":"10","key":"2019111821515466400_B21","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/MCB.24.10.4275-4293.2004","article-title":"Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice.","volume":"24","author":"Canela","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2019111821515466400_B22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(00)80053-9","article-title":"Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion.","volume":"10","author":"G\u00e4rtner","year":"1999","journal-title":"Immunity"},{"issue":"4","key":"2019111821515466400_B23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(00)80196-X","article-title":"T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver.","volume":"12","author":"Kawamoto","year":"2000","journal-title":"Immunity"},{"issue":"12","key":"2019111821515466400_B24","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2019111821515466400_B25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/asheducation-2006.1.331","article-title":"Therapy of peripheral T\/NK neoplasms.","volume":"2006","author":"Greer","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111821515466400_B26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/asheducation-2006.1.317","article-title":"Pathobiology of peripheral T-cell lymphomas.","volume":"2006","author":"Jaffe","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"2019111821515466400_B27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.lpm.2007.06.001","article-title":"[Angioimmunoblastic T-cell lymphoma].","volume":"36","author":"Lachenal","year":"2007","journal-title":"Presse Med"},{"issue":"2","key":"2019111821515466400_B28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1172\/JCI112860","article-title":"Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.","volume":"79","author":"Lipford","year":"1987","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111821515466400_B29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/jcp.39.11.1229","article-title":"Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.","volume":"39","author":"O'Connor","year":"1986","journal-title":"J Clin Pathol"},{"issue":"3","key":"2019111821515466400_B30","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"issue":"7","key":"2019111821515466400_B31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2019111821515466400_B32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2009.12","article-title":"Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.","volume":"22","author":"Rodriguez-Justo","year":"2009","journal-title":"Mod Pathol"},{"key":"2019111821515466400_B33","first-page":"309","article-title":"Angioimmunoblastic T-cell lymphoma.","volume-title":"Pathology and Genetics of Tumours of Haematopetic and Lymphoid Tissues: World Health Organisation Classification of Tumours","author":"Dogan","year":"2008"},{"issue":"3","key":"2019111821515466400_B34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","article-title":"A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.","volume":"12","author":"Saito","year":"2007","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111821515466400_B35","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood.V97.12.3902","article-title":"MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.","volume":"97","author":"Zhou","year":"2001","journal-title":"Blood"},{"issue":"16","key":"2019111821515466400_B36","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.1073\/pnas.1533446100","article-title":"Bad-deficient mice develop diffuse large B cell lymphoma.","volume":"100","author":"Ranger","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111821515466400_B37","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2019111821515466400_B38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.immuni.2011.11.001","article-title":"How T cells earn the follicular rite of passage.","volume":"35","author":"Vinuesa","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"2019111821515466400_B39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2019111821515466400_B40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.179.4.1173","article-title":"Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines.","volume":"179","author":"Lindhout","year":"1994","journal-title":"J Exp Med"},{"issue":"6","key":"2019111821515466400_B41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200106000-00003","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association.","volume":"25","author":"Cheuk","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2019111821515466400_B42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.humpath.2007.08.022","article-title":"Follicular dendritic cell tumor of the spleen associated with diffuse large B-cell lymphoma.","volume":"39","author":"Laurent","year":"2008","journal-title":"Hum Pathol"},{"issue":"5","key":"2019111821515466400_B43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma.","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111821515466400_B44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers.","volume":"32","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2019111821515466400_B45","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.1001730","article-title":"Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.","volume":"185","author":"Rolf","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"2019111821515466400_B46","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.4049\/jimmunol.1000202","article-title":"Signaling pathways in T follicular helper cells.","volume":"184","author":"Rolf","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"2019111821515466400_B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1097-2765(00)80108-2","article-title":"Ku70: a candidate tumor suppressor gene for murine T cell lymphoma.","volume":"2","author":"Li","year":"1998","journal-title":"Mol Cell"},{"issue":"4","key":"2019111821515466400_B48","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)65237-6","article-title":"A murine xenograft model for human CD30+ anaplastic large cell lymphoma: successful growth inhibition with an anti-CD30 antibody (HeFi-1).","volume":"155","author":"Pfeifer","year":"1999","journal-title":"Am J Pathol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/4\/812\/1498255\/zh803012000812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/4\/812\/1498255\/zh803012000812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:52:24Z","timestamp":1574131944000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/4\/812\/105610\/Heterozygosity-for-Roquinsan-leads-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-365130","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}